QMS Remediation Services for Medical Device Companies

Quality director and regulatory consultant reviewing inspection findings and corrective action evidence.

Move from inspection observations and recurring audit findings to a practical corrective action program. Elexes helps medical device companies assess known QMS weaknesses, investigate causes, plan remediation and organize evidence of implementation and effectiveness.

We support quality leaders, founders and operations teams responding to Form FDA 483 observations, certification findings, internal audit nonconformities or repeated process failures. Our QMS implementation and audit services connect focused remediation with your wider quality priorities.

When Closing the Finding Does Not Resolve the Problem

A revised SOP, completed training session or signed action tracker may address part of a finding while leaving the underlying failure in place. Repeat observations often reveal that the investigation was too narrow, implementation was incomplete or effectiveness was never demonstrated.

Elexes helps connect each finding with the affected process, potential product impact, investigation, action owner and evidence needed for review. The objective is a controlled remediation program your team can execute and explain.

FDA Audit 483: What Your Team Needs to Address

If you are searching for help with an FDA audit 483, the formal document is Form FDA 483, issued following an FDA inspection when investigators identify objectionable conditions. It is not a warning letter or a final agency determination of a violation.

FDA’s Form 483 FAQs encourage a written corrective action plan and prompt implementation. They also explain that companies should address related non-cited conditions, where present. 

The work should therefore extend beyond preparing a response letter. Establish what occurred, whether other products or processes are affected, what immediate controls are needed and how lasting corrective action will be demonstrated.

How Elexes Supports QMS Remediation

Finding Review, Priorities and Remediation Scope

We review the observations or audit report, relevant correspondence, previous responses and supporting records. We distinguish the stated finding from assumptions that need investigation and identify related process weaknesses.

Our QMS remediation program establishes a consolidated action roadmap with owners, priorities, dependencies and evidence expectations. Immediate containment, product impact and possible reporting obligations are assessed with your responsible quality and regulatory personnel where relevant.

Root-Cause Investigation and Corrective Action Planning

We assist the team in testing the potential causes against existing evidence instead of going for employee training or a policy change. The analysis will determine whether the deficiency applies to other procedures, records, suppliers, device models, or sites.

Through audit finding remediation, we support proportionate investigations and plans that distinguish immediate correction from action on the cause. Each action should have a responsible owner, target date and defined completion evidence.

Implementation and Supporting Records

An action plan needs to become operational. Depending on the agreed scope, remediation may involve revised procedures, workflow changes, retrospective record reviews, training, supplier controls or additional verification and validation activities.

We help organize the evidence linking approved changes to implementation. Historical gaps should be described accurately; missing evidence must not be replaced by backdated or invented records. Where substantial process rebuilding is needed, connect the work with QMS implementation services.

FDA Form 483 Response and Progress Updates

Our FDA quality system remediation workstream can include drafting or reviewing responses when expressly agreed. We organize the response by observation, distinguish completed actions from planned work and connect statements to supporting evidence.

When a task needs additional time, consider the interim control measures, a reasonable timeline, and the evidence yet to be provided. Determine your response time frame and procedure from the FDA’s letter. You authorize your designated team to commit and submit the response unless otherwise decided.

Effectiveness Review and Follow-Up

Describe how you will know that the correction was successful before closing out the corrective action. Possible evidence could be in the form of follow-up records, process performance, reoccurrence, or sampling.

Elexes can review completion and effectiveness evidence within the agreed scope. A separate medical device internal audit can provide a further check using an appropriately objective audit arrangement. Internal closure does not itself establish FDA acceptance or a certification body’s acceptance.

Quality engineer and production supervisor verifying a revised acceptance check.

Remediation Under Current FDA QMSR Requirements

The FDA Quality Management System Regulation became effective from February 2, 2026. The regulation includes ISO 13485:2016 by reference in addition to FDA requirements. The remediation action plan must be based not on the old templates but on the appropriate requirements and observations.

Our FDA QMSR consulting services support a focused requirements workstream. Formal inspections and regulatory decisions remain FDA responsibilities; Elexes provides consulting support.

What You Receive and How We Start

Share the results, dates of inspections/audits, communications, existing CAPA documentation and status. We will reach agreement on the process, locations, scope, timing and deliverables prior to beginning.

An engagement could result in creation of a consolidated plan for remediation and discussion of results. The process could involve generation of CAPA documents, document revisions, response drafts, evidence index and status reporting. Laboratory testing, validation, and legal counsel will have different requirements if needed.

Parul Chansoria, founder of Elexes, on connecting findings, causes, actions and evidence.

Review your finding register, immediate controls, investigation, corrective actions, supporting evidence and effectiveness criteria before the next progress meeting.

FAQs

Frequently Asked Questions!

No. Form FDA 483 records inspection observations. A warning letter is a separate FDA communication. The response and remediation approach should reflect the actual document received.

Yes. We could analyze the existing commitments, actions, and proof and then scope out implementation assistance or update on progress. Provide all communications to ensure that the work captures the current situation.

A revision may be one necessary action. Closure should also consider the cause, affected records or products, implementation evidence and appropriate effectiveness checks.

Not all actions need to be completed. Make sure that you separate completed tasks from planned actions, give a justification for the milestones, and explain the interim controls. Do not wait until all actions are completed to confirm the timing of the response.

No. Elexes supports accurate responses and evidence-based remediation. FDA evaluates the information and determines any further action.

Bring your observations, existing commitments and unresolved quality issues. Elexes will help define a focused remediation engagement with clear owners, deliverables and evidence requirements.
Turn findings into effective action with Elexes QMS remediation and FDA Form 483 response support.

A Trusted Team of Consultants

Elexes offers a globally recognized ISO 13485 certification consultant who is renowned to enhancing your business credibility in the medical devices industry.

Local Language
Auditor

Our presence across the globe ensures audits are conducted by local-language auditors, facilitating clear communication and understanding.

Why Choose Elexes?

Expertise

Our experts provide guidance and consultants to help you adhere to necessary regulations, ensuring your products meet all legal requirements and is compliant to all necessary standards.

Local Regulatory Certification

At Elexes, we offer to assist in securing additional local certifications, enabling you to manufacture and sell medical devices in various markets across the globe.

Confidentiality

We offer complete confidentiality to all our clients which makes us one of the most trusted regulatory and quality compliance consulting.

Associated Regulatory Authorities.

img
We’ve More
Than 256+ Global Clients
The Best RA & QA Consultants
Clients Testimonials

Amazing Feedback About Our Services

Popular Clients

We’ve 200+ Global Premium Clients

Saneso
Niramai
Apex dental sensors
Neurasignal
SS inovations
Amaryllis
Inclode
iMedisync
DJOGlobal logo cmyk_TM
Summus Laser Logo
Looking For Regulatory Assistance?

Let's Talk How We Can Help You?

Please enable JavaScript in your browser to complete this form.
Name
img
Please enable JavaScript in your browser to complete this form.
Name
img
Please enable JavaScript in your browser to complete this form.
Name
img
Please enable JavaScript in your browser to complete this form.
Name
img
Please enable JavaScript in your browser to complete this form.
Name
img